F545-2342 Screening compound: 3-{3-[3-(piperidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

F545-2342 Screening compound: 3-{3-[3-(piperidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole
F545-2342 Screening compound: 3-{3-[3-(piperidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole alternative view

Chemical Structure Depiction of ChemDiv screening compound F545-2342
3-{3-[3-(piperidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F545-2342

Molecular Formula

C21H23N5O2 (C21 H23 N5 O2)

Compound Name

3-{3-[3-(piperidine-1-carbonyl)phenyl]-1,2,4-oxadiazol-5-yl}-4,5,6,7-tetrahydro-1H-indazole

IUPAC name

3-{3-[3-(piperidine-1-carbonyl)phenyl]-124-oxadiazol-5-yl}-4567-tetrahydro-1H-indazole

SMILES

O=C(c1cc(-c2noc(-c3n[nH]c4c3CCCC4)n2)ccc1)N1CCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

377.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.472

Distribution Coefficient, logD

3.472

Water Solubility, LogSw

-3.70

Polar Surface Area

73.246

Acid Dissociation Constant (pKa)

14.65

Base Dissociation Constant (pKb)

0.53

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

F545-2342 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

Cardiovascular Library (22201 compounds)

GPCR Targeted Library (31838 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cardiovascular
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F545-2342 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F545-2342?
Check Price and Availability of F545-2342, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F545-2342 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F545-2342
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F545-2342
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F545-2342 available by request